Skip to main content
Home Start-Ups

Have Questions?

Please contact us or subscribe for more opportunities

Stay in Touch with Us

See what’s new.

https://otc.duke.edu/wp-content/uploads/2023/03/lacuna-medical-ducap-fundraise-pr-featured.png

Duke Capital Partners Leads Investment in Lacuna Medical

Lacuna Medical is Developing a 3D Shape Catheter that is More Resistant to Failure

Read More

https://otc.duke.edu/wp-content/uploads/2023/03/evecxia-logo.png

Evecxia Therapeutics Reports Favorable Data From a Phase 1 Single Ascending Dose Safety/Tolerability/PK/PD Trial of EVX-301

Evecxia Therapeutics is a Duke University start-up, founded by inventors Drs. Jacob Jacobsen and Marc Caron (Cell Biology, SOM) around their serotonin synthesis amplification therapeutic technology for mental health applications.

Read More

https://otc.duke.edu/wp-content/uploads/2023/03/Isolere-acquisition-story-cover.jpeg

Isolere Bio: Inside the journey of a Duke biotech start-up

From an invention in 1999, to start-up creation in 2017, to acquisition in 2023, learn of the twists and turns of Duke start-up Isolere Bio from its co-founders.

Read More

https://otc.duke.edu/wp-content/uploads/2023/02/isolere-logo.png

Donaldson Acquires Isolere Bio, Continuing to Build Life Sciences Business

“Isolere is thrilled to join the Donaldson family and bring our novel affinity-phase separation technology to market,” said Kelli Luginbuhl, Ph.D, co-founder and chief executive officer of Isolere.

Read More

https://otc.duke.edu/wp-content/uploads/2023/02/Xilis-logo.jpeg

Xilis and MD Anderson Announce Strategic Collaboration to Advance Novel Technology and Accelerate Therapeutic Development

Preclinical research agreement brings together Duke start-up Xilis' MicroOrganoSphere™ platform with MD Anderson's expertise in cancer research and therapeutic development.

Read More

https://otc.duke.edu/wp-content/uploads/2023/02/Screen-Shot-2023-02-08-at-2.44.42-PM.jpeg

Sparta Biomedical, Dr. Wiley highlighted by WXII 12 News

Professor of Chemistry Dr. Benjamin Wiley was interviewed recently by Winston-Salem TV station WXII 12 News about the synthetic cartilage his lab developed.

Read More

https://otc.duke.edu/wp-content/uploads/2023/02/Manny-stockman-summary-featured-Jan-2023.png

Video and Slides: Manny Stockman Seminar on Start-Up Founding

On January 31st, 2023, Manny Stockman of the venture capital investment firm Osage University Partners, delivered a talk titled: Start-Up Seminar: Founders Equity, Dilution Planning, and Term Sheets. In this post you will find the…

Read More

https://otc.duke.edu/wp-content/uploads/2023/02/IstariOncologyLogoFullColor.jpeg

Istari Oncology Announces First Patient Dosed in the Non-Muscle-Invasive Bladder Cancer (NMIBC) Substudy of the LUMINOS-103 Basket Trial Evaluating Lerapolturev Monotherapy

Istari Oncology was founded by Drs. Darell Bigner and Matthias Gromeier (Neurosurgery, SOM).

Read More

https://otc.duke.edu/wp-content/uploads/2023/01/11B5C88A-E824-48AC-B630-1E8815D4E436.jpg

Celebrating Major Milestones in Personalized Orthopaedics, restor3d Announces First Surgery Using the Next Generation Kinos Axiom® Total Ankle System Featuring TIDAL Technology™ and Launches Mobile Companion App of r3id Personalized Surgery Platform

restor3d, a leading medical device company that develops innovative technologies and manufactures 3D printed implants and instruments, celebrates two incredible company milestones. The first being the successful implantation of the next generation Kinos Axiom® Total Ankle…

Read More

1 2 3 27